Skip to content

PHARMACELL

Active Risk: not assessed Private limited companyfounded 2019active for 6 yearsWortegemplein (W.) 9, 9790 Wortegem-PetegemKBO/BCE: BE 0738.956.985

Board

1 director, since incorporation
Director
since 09-12-2019 term without a fixed end
listed in the 2025 annual accounts, filed on 26-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 13-12-2019

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director
Board
Mandates as a list
    • Director, from 09-12-2019 to date

Control

Founder
This company
PHARMACELL
Equity €494,200
Profit €223,035 in 2025

Capital

Contribution
€300,000
Shares
1,000
Contribution per share
€300
Equity per share
€494 in 2025
Source
deed of 13-12-2019

Articles of association

deed of 13-12-2019 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Saturday of June at 11:00
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Alle machten genoemd in artikel 2:87 WVV zonder bijzondere machtiging algemene vergadering, desgevallend voor te leggen aan voorzitter…”

Founder

At incorporation deed of 13-12-2019 ↗
  • sole founder · 100% at incorporation

Next steps